Flu Vaccine Market, By Type (Split Virus Vaccines, Sub-unit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

The global influenza vaccination market grew due to an increase in the number of patients. Additionally, the government employs various tactics to increase the number of people who get the flu shot nationwide. Rising public awareness of infectious diseases has recently resulted in timely vaccination campaigns in emerging economies. Different nations implemented their immunization programs in various ways.

The primary factor impeding the market's expansion may be the lengthier timeframe required for vaccine production. Producing a novel vaccine is lengthy; introducing a suitable vaccination for a disease often takes 10–14 years. Another factor limiting the growth of flu vaccines is the longer the vaccines are legalized.